Skip to main content
. 2013 Jan-Feb;20(1):23–25. doi: 10.1155/2013/183948

Figure 1).

Figure 1)

Number of severe asthma exacerbations in patients treated with mepomalizumab 75 mg, 250 mg or 750 mg or placebo for one year.ACumulative number of asthma exacerbations with time.BDistribution of number of asthma exacerbations. Reproduced with permission from reference 17